Scale-up of adipose tissue-derived mesenchymal stem cell production in stirred single-use bioreactors under low-serum conditions

Engineering in Life Sciences

Volumn 14, Issue 3, 2014, Pages 292-303

  Schirmaier, Carmen ^a   Jossen, Valentin ^a   Kaiser, Stephan C ^a   Jüngerkes, Frank ^b   Brill, Silke ^b   Safavi Nab, Agnieszka ^b   Siehoff, Ann ^b   van den Bos, Christian ^b   Eibl, Dieter ^a   Eibl, Regine ^a  

^a ZURICH UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

^b Lonza Cologne GmbH   (Germany)

Author keywords

Adipose tissue derived mesenchymal stem cells; Microcarrier; Scale up; Serum reduced medium; Stirred single use bioreactor

Indexed keywords

BIOCONVERSION; BIOREACTORS; BODY FLUIDS; CELL CULTURE; STEM CELLS; TISSUE;

ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS; MICROCARRIERS; SCALE-UP; SERUM-REDUCED MEDIUM; SINGLE USE;

TISSUE ENGINEERING;

BIOENGINEERING; BIOREACTOR; CYTOLOGY; FAT; OPERATIONS TECHNOLOGY; PARAMETERIZATION; PERFORMANCE ASSESSMENT; SERUM; TECHNOLOGICAL DEVELOPMENT;

ADIPOSE TISSUE; ARTICLE; BIOREACTOR; CELL LINE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMPELLER; KOLMOGOROV SMIRNOV TEST; MESENCHYMAL STEM CELL; MICROCARRIER CULTURE; NEODYMIUM YAG LASER; SCALE UP; SHEAR STRESS; TURBULENT FLOW;

EID: 84901273738     PISSN: 16180240     EISSN: 16182863     Source Type: Journal    
DOI: 10.1002/elsc.201300134     Document Type: Article

References (41)

1. Wang, J., Liao, L., Tan, J., Mesenchymal-stem-cell-based experimental and clinical trials: Current status and open questions. Expert Opin. Biol. Ther. 2011, 11, 893-909.
2. Meirelles Lda, S., Fontes, A. M., Covas, D. T., Caplan, A. I., Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009, 20, 419-427.
3. Ren, G., Chen, X., Dong, F., Li, W. et al., Concise review: Mesenchymal stem cells and translational medicine: Emerging issues. Stem Cells Transl. Med. 2012, 1, 51-58.
4. Li, W., Ren, G., Huang, Y., Su, J. et al., Mesenchymal stem cells: A double-edged sword in regulating immune responses. Cell Death Differ. 2012, 19, 1505-1513.
5. Khan, W. S., Hardingham, T. E., Mesenchymal stem cells, sources of cells and differentiation potential. J. Stem Cells 2012, 7, 75-85.
6. De Miguel, M. P., Fuentes-Julian, S., Blazquez-Martinez, A., Pascual, C. Y. et al., Immunosuppressive properties of mesenchymal stem cells: Advances and applications. Curr. Mol. Med. 2012, 12, 574-591.
7. Najafi, R., Sharifi, A. M., Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats. Expert Opin. Biol. Ther. 2013, 13, 959-972.
8. Horwitz, E. M., Gordon, P. L., Koo, W. K., Marx, J. C. et al., Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc. Natl. Acad. Sci. USA 2002, 99, 8932-8937.
9. El-Badri, N., Ghoneim, M. A., Mesenchymal stem cell therapy in diabetes mellitus: Progress and challenges. J. Nucleic Acids 2013, 2013, 194858.
10. Roemeling-van Rhijn, M., Weimar, W., Hoogduijn, M. J., Mesenchymal stem cells: Application for solid-organ transplantation. Curr. Opin. Organ Transplant. 2012, 17, 55-62.
11. Voswinkel, J., Francois, S., Gorin, N. C., Chapel, A., Gastro-intestinal autoimmunity: Preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells. Immunol. Res. 2013, 56, 241-248.
12. Molendijk, I., Duijvestein, M., van der Meulen-de Jong, A. E., van Deen, W. K. et al., Immunomodulatory effects of mesenchymal stromal cells in Crohn's disease. J. Allergy 2012, 2012, 187408.
13. Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N. et al., A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (Prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 2009, 54, 2277-2286.
14. Harting, M. T., Jimenez, F., Xue, H., Fischer, U. M. et al., Intravenous mesenchymal stem cell therapy for traumatic brain injury. J. Neurosurg. 2009, 110, 1189-1197.
15. Park, J. H., Kim, D. Y., Sung, I. Y., Choi, G. H. et al., Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. Neurosurgery 2012, 70, 1238-1247.
16. Friedenstein, A. J., Piatetzky, S., II, Petrakova, K. V., Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 1966, 16, 381-390.
17. Caplan, A. I., Why are MSCs therapeutic? New data: New insight. J. Pathol. 2009, 217, 318-324.
18. Moretti, P., Hatlapatka, T., Marten, D., Lavrentieva, A. et al., Mesenchymal stromal cells derived from human umbilical cord tissues: Primitive cells with potential for clinical and tissue engineering applications. Adv. Biochem. Eng. Biotechnol. 2010, 123, 29-54.
19. Orbay, H., Tobita, M., Mizuno, H., Mesenchymal stem cells isolated from adipose and other tissues: Basic biological properties and clinical applications. Stem Cells Int. 2012, 2012, 461718.
20. Sharma, S., Raju, R., Sui, S., Hu, W. S., Stem cell culture engineering-process scale up and beyond. Biotechnol. J. 2011, 6, 1317-1329.
21. Van den Bos, C., Keefe, R., Schirmaier, C., McCaman, M., Therapeutic human cells: Manufacture for cell therapy/regenerative medicine. Adv. Biochem. Engin./Biotechnol. 2012, 138, 61-97.
22. Cierpka, K., Elseberg, C. L., Kiss, K., Kassem, M. et al., MSC production in disposable bioreactors with regards to GMP and PAT. Chemie. Ingenieur Technik. 2013, 85, 67-75.
23. Jing, D., Sunil, N., Punreddy, S., Aysola, M. et al., Growth kinetics of human mesenchymal stem cells in a 3-L single-use, stirred-tank bioreactor. BioPharm. Int. 2013, 26, 28-38.
24. Kehoe, D., Schnitzler, A., Simler, J., DiLeo, A., Ball, A., Scale-up of human mesenchymal stem cells on microcarriers in suspension in a single-use bioreactor. BioPharm. Int. 2012, 25, 28-38.
25. Kaiser, S. C., Jossen, V., Schirmaier, C., Eibl, D. et al., Fluid flow and cell proliferation of mesenchymal adipose-derived stem cells in small-scale, stirred, single-use bioreactors. Chemie. Ingenieur Technik. 2013, 85, 95-102.
26. Ibrahim, S., Nienow, A. W., Suspension of microcarriers for cell culture with axial flow impellers. Chem. Eng. Res. Des. 2004, 82, 1082-1088.
27. Liepe, F., Sperling, R., Jembere, J., Rührwerke: Theoretische Grundlagen, in: Auslegung und Bewertung. Köthen, Eigenverlag FH Anhalt 1998.
28. Jung, S., Panchalingam, K. M., Rosenberg, L., Behie, L. A., Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int. 2012, 2012, 123030.
29. Rafiq, Q. A., Coopman, K., Hewitt, C. J., Scale-up of human mesenchymal stem cell culture: Current technologies and future challenges. Curr. Opin. Chem. Eng. 2013, 2, 8-16.
30. Yang, S., Pilgaard, L., Chase, L. G., Boucher, S. et al., Defined xenogeneic-free and hypoxic environment provides superior conditions for long-term expansion of human adipose-derived stem cells. Tissue Eng. Part C Methods 2012, 18, 593-602.
31. Fekete, N., Rojewski, M. T., Furst, D., Kreja, L. et al., GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PloS ONE 2012, 7, e43255.
32. Chase, L. G., Yang, S., Zachar, V., Yang, Z. et al., Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells. Stem. Cells Transl. Med. 2012, 1, 750-758.
33. Jung, S., Panchalingam, K. M., Wuerth, R. D., Rosenberg, L. et al., Large-scale production of human mesenchymal stem cells for clinical applications. Biotechnol. Appl. Biochem. 2012, 59, 106-120.
34. Bohnet, M., Niesmark, G., Distribution of solids in stirred suspenison. German Chem. Eng. 1980, 3, 57-65.
35. Kaiser, S. C., Löffelholz, C., Werner, S., Eibl, D., CFD for characterizing standard and single-use stirred cell culture bioreactors, in: Minin, J. (Ed.), Computational Fluid Dynamics, InTech, Rijeka Croatia 2011, pp. 97-122.
36. Löffelholz, C., Husemann, U., Greller, G., Meusel, W. et al., Bioengineering parameters for single-use bioreactors: Overview and evaluation of suitable methods. Chemie. Ingenieur Technik. 2013, 85, 40-56.
37. Kaiser, S. C., Eibl, R., Eibl, D., Engineering characteristics of a single-use stirred bioreactor at bench-scale: The Mobius CellReady 3L bioreactor as a case study. Eng. Life Sci. 2011, 11, 359-368.
38. Hewitt, C. J., Lee, K., Nienow, A. W., Thomas, R. J. et al., Expansion of human mesenchymal stem cells on microcarriers. Biotechnol Lett. 2011, 33, 2325-2335.
39. Höfken, M., Schäfer, M. F. D., Detaillierte Untersuchung des Strömungsfeldes innerhalb eines Sechs-Blatt-Scheibenrührers. Chemie. Ingenieur Technik. 2004, 68, 803-809.
40. Wu, H., Patterson, G. K., Van Doorn, M., Distribution of turbulence energy dissipation rates in a Rushton turbine stirred mixer. Exp. Fluids 1989, 8, 153-160.
41. Rafiq, Q. A., Brosnan, K. M., Coopman, K., Nienow, A. W. et al., Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor. Biotechnol. Lett. 2013, 35, 1233-1245.